DOES MEDICARE SAVE LIVES?

The Quarterly Journal of Economics
David CardNicole Maestas

Abstract

Health insurance characteristics shift at age 65 as most people become eligible for Medicare. We measure the impacts of these changes on patients who are admitted to hospitals through emergency departments for conditions with similar admission rates on weekdays and weekends. The age profiles of admissions and comorbidities for these patients are smooth at age 65, suggesting that the severity of illness is similar on either side of the Medicare threshold. In contrast, the number of procedures performed in hospitals and total list charges exhibit small but statistically significant discontinuities, implying that patients over 65 receive more services. We estimate a nearly 1-percentage-point drop in 7-day mortality for patients at age 65, equivalent to a 20% reduction in deaths for this severely ill patient group. The mortality gap persists for at least 9 months after admission.

Citations

Dec 19, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Robert Kaestner
Feb 18, 2011·Journal of Public Health Policy·Peter S ArnoClyde Schechter
Jan 8, 2013·The Quarterly Journal of Economics·Amy FinkelsteinUNKNOWN Oregon Health Study Group
Oct 28, 2014·American Economic Journal. Applied Economics·Grant MillerMarcos Vera-Hernández
Jul 16, 2014·International Journal of Health Care Finance and Economics·Sam Peltzman
Jul 2, 2014·Journal of Health Economics·Denise DoironAgne Suziedelyte
Oct 19, 2010·Journal of Health Economics·Robert W FairlieSusan Gates
Aug 8, 2015·Journal of Health Economics·Jessamyn Schaller, Ann Huff Stevens
May 26, 2011·Health Services Research·Jack HadleyRobert A Berenson
Mar 31, 2012·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Tom Miller
Mar 13, 2015·Health Economics·Marcus Dillender, Karen Mulligan
Dec 24, 2013·Journal of Policy Analysis and Management : [the Journal of the Association for Public Policy Analysis and Management]·Charles J Courtemanche, Daniela Zapata
Sep 1, 2015·American Journal of Surgery·Tiffany L OvertonShahid Shafi
Sep 25, 2015·Journal of Economic Literature·Dora Costa
Feb 11, 2015·Journal of Health Economics·Padmaja Ayyagari, Dan M Shane
Apr 23, 2016·American Journal of Preventive Medicine·Jacob Wallace, Benjamin D Sommers
Apr 13, 2013·Journal of Health Economics·Thomas G Koch
Apr 9, 2014·Journal of Health Economics·Hitoshi Shigeoka, Kiyohide Fushimi
Nov 20, 2012·Social Science & Medicine·Te-Fen Lo, Chee-Ruey Hsieh
Sep 2, 2014·Journal of Health Economics·Ronen Avraham, Max Schanzenbach
Apr 26, 2016·Community Dentistry and Oral Epidemiology·Stefan ListlRichard G Watt
Jun 19, 2016·BMC Infectious Diseases·Yitzchok M NorowitzTamar A Smith-Norowitz
Nov 20, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kevin F EricksonJay Bhattacharya
Mar 30, 2017·Journal of Clinical Epidemiology·Hugh WaddingtonBarney Reeves
May 12, 2016·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Marco D Huesch, Michael K Ong
May 12, 2016·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Marco D Huesch, Michael K Ong
Oct 12, 2010·Health Affairs·Peter A Muennig, Sherry A Glied
Oct 3, 2018·International Journal of Environmental Research and Public Health·Yingying MengSiqi Qin
May 9, 2019·Health Services Research·Nicolae DoneTim Xu
Oct 31, 2019·Journal of the American Geriatrics Society·Brandy J Lipton
Apr 20, 2014·Science·Francesca DominiciCass R Sunstein
Nov 28, 2019·The International Journal of Health Planning and Management·Yingying MengJunqiang Han

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.